Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/Amlodipine vs Lisinopril/HCTZ in Severe Hypertension
NCT00171535Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of valsartan and amlodipine in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Adverse events and serious adverse events at 6 weeks. Started Oct 2004; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00171535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171535.